That is very important, since the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work. Simply put, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been an experimental process (tech predictions). Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're developed to do. This was an advancement nearly no one noticed. But it's going to have profound ramifications for curing illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be plenty of financial investment opportunities in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown). That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it drew back maybe significantly before going greater - jeff bezos. I have actually been covering bitcoin for a very long time now. Among the first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were mostly informing readers. But that's not the big concern any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So think about that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. jeff brown 2021 stock predictions. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are many fantastic personal business on the edge of hitting the general public markets And I've been working on a brand-new way for you to invest even before these business go public.
This chance has actually been building over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to schedule your area for complimentary.
Emma Walsh here, handling editor of the Journal. Routine Journal readers know that tech isn't our normal beat (genetic sequencer stock jeff brown). And when it concerns tech investing, we leave it to the experts. The good news is, we have numerous such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing experts we understand (the legacy report prediction). In fact, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the huge picture and forecast what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These patterns are experiencing rapid development and developing amazing opportunities for financiers. I desire to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. united arab emirates. But in spite of what many readers might believe, this is a trend that's simply beginning. Although the COVID-19 pandemic interrupted supply chains last year, an excellent 250 million 5G-enabled devices were still offered.
And all of this eventually led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (future report). Losing two months of manufacturing and sales actually impacts how numerous 5G devices are offered in the calendar year. When you consider all of that, selling 250 million systems is exceptional. More importantly, the delays brought on by the pandemic produced a lot of bottled-up demand. Which demand is now going to be pressed into 2021. In truth, I predict that more than 500 million 5G devices will be shipped in 2021 - legacy report prediction. Which's not my only 5G prediction When I have actually spoken about 5G in the past, I've described its 3 various phases.
In Phase 2, 5G devices go on sale. 5G phones and other items start to reach customers. And in Stage Three, 5G services begin to be used (jeff brown stock predictions). That's when we start to see applications working on 5G networks. Consider things like massive multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Phase 3 by this summer season. This starts something of a virtuous cycle: The majority of people do not truly appreciate the technology. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In truth, 5G is going to open a suite of amazing applications: self-driving vehicles, the Internet of Things, robotic surgery, and more. All of these innovations need 5G. The investment chances going forward will be massive. Stepping far from 5G, the next important innovation I foresee in 2021 is CRISPR hereditary editing. CRISPR represents "clustered routinely interspaced brief palindromic repeat." It's a mouthful. However it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software.
The program can crash or not function correctly. CRISPR utilizes a comparable concept however with our genetic code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For years, CRISPR was mostly a niche technology that wasn't well comprehended. And during that time, there were really just three business operating in this area. However things are changing. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this technology just works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and delivering amazing returns. This entire market is efficiently a greenfield chance.
There's space for lots of business to exist in this space. genetic sequencing companies jeff brown. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or 3 more hereditary editing business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software can accurately predict the folding of a protein based entirely on its amino acid series with 92. 4% accuracy. That is necessary since the way a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be effective.
Historically, this has actually been a trial-and-error process. But now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to develop drugs that do what they're developed to do. And here's my next prediction. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one but a number of drug therapies produced using this technology. This was one of those breakthroughs that nearly nobody saw. However it's going to have extensive implications for curing disease. And, obviously, there will be a lot of financial investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it pulled back possibly significantly prior to going greater. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever released was on bitcoin - jeff brown stock predictions. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. However at the time of that initial recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. jeff brown biotech stock pick for 2020. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more benefit forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the details depends on date since February 2021, but we might not independently confirm this claim. Provided Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an exact figure at this moment. Brown is best known for his sage-like ability to select winning technology stocks. He spent more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience offers him an exceptional perspective on the marketplace. He's always on the hunt for brand-new chances, and he shares a lot of his best choices in the Future Report.
That's high praise, however it's not ridiculously reasoned. Brown has an outstanding reputation as a stock-picker, and he effectively predicted some of the biggest financial events of the past 20 years. Although he does not appear to launch his choices to the public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it ideal every time, but Jeff Brown's accurate predictions have made him legions of dedicated fans. That states a lot about his ability. The Near Future Report is published by Brownstone Research study, a popular financial research study publisher. Brownstone Research provides a number of research study services with a wide array of specializations - jeff brown biotech stock pick for 2020.
The company is likewise connected with Bonner & Partners, another well-respected research publisher - tech predictions. On its website, Brownstone states its objective is to supply retail financiers with professional-grade research study: "For too long, the very best investment research has actually not been offered to specific investors. It has been usually booked for investment banks, hedge funds, private equity, and high-net-worth customers. exponential growth. The objective of Brownstone Research is to make that type of proprietary research readily available to any financiers aiming to get an edge in the marketplaces. The goal is basic to provide unique and successful financial investment research study found nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise acts as the firm's Chief Investment Expert.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to provide its customers. After decades of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout many of America. If you know even a little bit about the marketplace, you know that he has a reputation as a King Midas of sorts. jeff brown genome sequencing. Whatever he touches turns to gold! Jeff is well mindful of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge project.
In reality, Brown thinks S.A.V. the legacy report predictions. might be "the greatest trend of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying 2 innovative technologies: expert system and electrical cars and trucks. Musk hopes the mix will assist him establish the very first fully-autonomous, self-driving cars ever. It's nothing except the automotive market's Holy Grail. As you know, electric cars and self-driving cars and truck stocks have been huge this year, but the Wall Street device has actually been huge on hype without much tangible result. In spite of an extreme increase in competition over the past few years, Brown still thinks Musk has the very best possibility of putting it all together.
tech might be the magic string that connects all of it together. S.A.V. stands for Shared Autonomous Lorry, and it might be the future of transport. Essentially, this technology would allow you to rent your automobile as an autonomous, self-driving taxi when you're not utilizing it. You merely leave the vehicle and press a button on an app that informs the cars and truck to "join the fleet." Next thing you know, you're relaxing on your sofa while your car shuttles ride-sharers around town. Best of all, you get to keep a significant piece of the earnings. It sounds crazy, but it might be closed than you believe.